A novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 373-380

  Xiong, Z ^a   Liu, E ^b   Yan, Y ^a   Silver, R T ^c   Yang, F ^a   Chen, I H ^a   Hodge, I ^a   Verstovsek, S ^d   Segura, F J ^e   Wang, H ^a   Prchal, J ^f   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

IgG antibody responses; Polycythemia vera; SEREX; Tumor antigen; Unconventional antigen

Indexed keywords

ALPHA INTERFERON; ANAGRELIDE; COMPLEMENTARY DNA; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN G; MPD5 PROTEIN; PROTEIN DERIVATIVE; THALIDOMIDE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANTIBODY RESPONSE; ANTIGENICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; EXON; GENE STRUCTURE; GRANULOCYTE; HUMAN; HUMORAL IMMUNITY; INTRON; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SEROLOGY; TESTIS; TREATMENT RESPONSE; UPREGULATION;

EID: 34547129066     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000218     Document Type: Article

References (25)

1. Lengfelder E., U. Berger and R. Hehlmann. 2000. Interferon alpha in the treatment of polycythemia vera. Ann. Hematol. 79:103.
2. Liu E., J. Jelinek, Y.D. Pastore, Y. Guan, J.F. Prchal and J.T. Prchal. 2003. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101:3294.
3. Xiong Z., E. Liu, Y. Yan, R.T. Silver, F. Yang, I.H. Chen, Y. Chen, S. Verstovsek, H. Wang, J. Prchal and X.F. Yang. 2006. An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions. J. Immunol. 177:4907.
4. Wu C.J., X.F. Yang, S. Mclaughlin, D. Neuberg, C. Canning, B. Stein, E.P. Alyea, R. J. Soiffer, G. Dranoff and J. Ritz. 2000. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J. Clin. Invest. 106:705.
5. Yang X.F., C.J. Wu, S. Mclaughlin, A. Chillemi, K.S. Wang, C. Canning, E.P. Alyea, P. Kantoff, R.J. Soiffer, G. Dranoff and J. Ritz. 2001. CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 98:7492.
6. Yang X.F., C.J. Wu, L. Chen, E.P. Alyea, C. Canning, P. Kantoff, R.J. Soiffer, G. Dranoff and J. Ritz. 2002. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. Cancer Res. 62:5517.
7. Wu C. J., M. Biernacki, J.L. Kutok, S. Rogers, L. Chen, X.F. Yang, R.J. Soiffer and J. Ritz. 2005. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells. Clin. Cancer Res. 11:4504.
8. Yang F. and X.F. Yang. 2005. New concepts in tumor antigens: their significance in future immunotherapies for tumors. Cell. Mol. Immunol. 2:331.
9. Yang X.F., G.F. Weber and H. Cantor. 1997. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7:629.
10. Ng B., F. Yang, D.P. Huston, Y. Yan, Y. Yang, Z. Xiong, L.E. Peterson, H. Wang and X.F. Yang. 2004. Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J. Allergy Clin. Immunol. 114:1463.
11. Smith J.K., A.A. Siddiqui, G.A. Krishnaswamy, R. Dykes, S.L. Berk, M. Magee, W. Joyner and J. Cummins. 1999. Oral use of interferon-alpha stimulates ISG-15 transcription and production by human buccal epithelial cells. J. Interferon Cytokine Res. 19:923.
12. Rosner B. 2000. Multisample Inference. In Fundamentals of Biostatistics. B. Rosner, Fifth edition, ed. Duxbury Thomas Learning. Australia, Canada, Mexico, Singapore, Spain, United Kingdom, United States, p. 511.
13. Yin M.J., L. Shao, D. Voehringer, T. Smeal and B. Jallal. 2003. The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J. Biol. Chem. 278:52454.
14. Romeo G., G. Fiorucci, M.V. Chiantore, Z.A. Percario, S. Vannucchi and E. Affabris. 2002. IRF-1 as a negative regulator of cell proliferation. J. Interferon Cytokine Res. 22:39.
15. Luo J.L., H. Kamata and M. Karin. 2005. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115: 2625.
16. Kozak M. 1996. Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome 7:563.
17. Furuno M., T. Kasukawa, R. Saito, J. Adachi, H. Suzuki, R. Baldarelli, Y. Hayashizaki and Y. Okazaki. 2003. CDS annotation in full-length cDNA sequence. Genome Res. 13:1478.
18. Yan Y., L. Phan, F. Yang, M. Talpaz, Y. Yang, Z. Xiong, B. Ng, N.A. Timchenko, C. J. Wu, J. Ritz, H. Wang and X.F. Yang. 2004. A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L. J. Immunol. 172:651.
19. Chen Y. 2004. SEREX review. Cancer Immunity http://www.cancerimmunity.org/SEREX/
20. Yang X., D. Mirkovic, S. Zhang, Qe. Zhang, Y. Yan, Z. Xiong, F. Yang, I.H. Chen, L. Li and H. Wang. 2006. Processing sites are different in the generation of HLA-A2.1-restricted T cell reactive tumor antigen epitopes and viral epitopes. Intl. J. Immunopathol. Pharmacol. 19:853.
21. Shastri N., S. Schwab and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463.
22. Yan Y., Y. Chen, F. Yang, I.H. Chen, Z. Xiong, J. Wang, L.B. Lachman, H. Wang and X-F. Yang. 2007. HLA-A2.1-restricted T cells are reacted to SEREX-defined tumor antigen CML66L and suppressed by CD4+CD25+ regulatory T cells. Int. J. Immunopathol. Pharmacol. 20:75.
23. Lu L., M.B. Werneck and H. Cantor. 2006. The immunoregulatory effects of Qa-1. Immunol. Rev. 212:51.
24. Nurieva R.I. 2005. Regulation of immune and autoimmune responses by ICOS-B7h interaction. Clin. Immunol. 115:19.
25. Yang F., I.H. Chen, Z. Xiong, Y. Yan, H. Wang and X.F. Yang. 2007. Model of stimulation-responsive splicing and strategies in identification of immunogenic isoforms of tumor antigens and autoantigens. Clin. Immunol. 122:279.